Are heart failure symptoms impacting your life? You are not alone. Millions of people worldwide suffer from these life-altering symptoms. BAROSTIM THERAPY is an effective solution to safely reduce symptoms of heart failure.
BAROSTIM NEO is proven to safely reduce symptoms of heart failure.
Real stories from patients that have asked if the BAROSTIM NEO is right for them.
BAROSTIM NEO addresses a significant unmet medical need in the treatment of heart failure.
BAROSTIM NEO is an implantable device that is clinically proven to safely reduce symptoms of heart failure.
CVRx is committed to the continued publication of clinical evidence supporting the benefit of BAROSTIM THERAPY for the treatment of heart failure.
CVRx provides full BAROSTIM THERAPY Patient Access Program support to all providers.
Learn more about BAROSTIM THERAPY clinical evidence, patient selection and implant procedure from the experts.
CVRx is committed to the generation of clinical evidence, including investigator-sponsored research, to support the adoption and access to our therapies.
CVRx® is a leader in innovative technologies that address the unmet needs in cardiovascular diseases with safe and effective therapies.
We are proud of our reputation for attracting some of the brightest leaders in the medical technology industry.
Latest press releases and company statements.
Downloads are made available to provide background information about us, our products and the conditions they treat.
JACC: HEART FAILURE - JUNE 2021